Yan Ma

机构：Hebei Agricultural University, Qingdao University, Harbin Medical University, Bengbu Medical College, Qingdao Mental Health Center, Taian City Central Hospital, Hebei University, Shaanxi University of Science and Technology · ORCID：0000-0002-1148-9572

发表论文 80 篇 · 总被引 1239 次 · h-index 18

代表论文

• Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial (2021 · Frontiers of Medicine · 被引 80)
• The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus (2021 · Journal of Diabetes Research · 被引 53)
• T Cells Expanded from PD-1+ Peripheral Blood Lymphocytes Share More Clones with Paired Tumor-Infiltrating Lymphocytes (2021 · Cancer Research · 被引 40)
• Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer (2021 · Cancer Science · 被引 33)
• Tumor-Associated Antigens (TAAs) for the Serological Diagnosis of Osteosarcoma (2021 · Frontiers in Immunology · 被引 18)
• Truscreen Detection of Cervical Tissues for High-Risk Human Papillomavirus-Infected Women During the COVID-19 Pandemic (2020 · Future Oncology · 被引 16)